Recombinant IL13 (Tralokinumab Biosimilar) anticorps

N° du produit ABIN7487857

Détail du produit anti-IL13 (Tralokinumab Biosimilar) anticorps

Antigène: IL13 (Tralokinumab Biosimilar)

Type d'anticorp: Recombinant Antibody

Reactivité: Humain

Hôte: Mammalian Cells

Expression System: Mammalian cells

Clonalité: Monoclonal

Application: ELISA

Fonction: Tralokinumab Biosimilar - Anti-IL13 mAb

Attributs du produit: Antibody Type: IgG4-lambda

Purification: Recombinant antibody expressed in mammalien cells and purified.

Classe de qualité: Research Grade

Isotype: IgG4 lambda

Information d'application

Restrictions: For Research Use only

Stockage

Buffer: PBS pH 7.5

Stock: -80 °C

Stockage commentaire: store at -80°C

Détails sur IL13 (Tralokinumab Biosimilar)

Antigène: IL13 (Tralokinumab Biosimilar)

Classe de substances: Biosimilar

Sujet: CAT-354
Tralokinumab is a human monoclonal antibody which targets the cytokine interleukin 13, and is designed for the treatment of asthma and inflammatory diseases.

Numéro CAS: 1044515-88-9